Literature DB >> 20438040

Decreased contrast sensitivity in children and adolescents with type 1 diabetes mellitus.

Constantine D Georgakopoulos1, Maria I Eliopoulou, Artemis M Exarchou, Vasileios Tzimis, Nikolaos M Pharmakakis, Bessie E Spiliotis.   

Abstract

PURPOSE: To evaluate contrast sensitivity in children and adolescents with diabetes mellitus without evidence of diabetic retinopathy.
METHODS: Sixty patients with insulin-dependent diabetes mellitus (age range: 8 to 18 years) were studied. Their contrast sensitivity scores were obtained using the CSV-1000 device (Vector Vision, Dayton, OH) for four spatial frequencies and were compared with v scores of 45 age-matched and gender-matched "healthy" patients. Contrast sensitivity values were also correlated to patient's age, duration of disease, and metabolic control of diabetes mellitus.
RESULTS: The patients with insulin-dependent diabetes mellitus had a significant contrast sensitivity score reduction at all spatial frequencies tested. Glycosylated hemoglobin levels were inversely related to the contrast sensitivity thresholds. No significant correlation was found between the contrast sensitivity scores and the patient's age or duration of disease.
CONCLUSION: Contrast sensitivity defects are detected in patients with insulin-dependent diabetes mellitus. These defects may represent an early dysfunction of the retina, visual pathway, or both in patients with insulin-dependent diabetes mellitus who do not show any signs of diabetic retinopathy. Copyright 2011, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20438040     DOI: 10.3928/01913913-20100420-02

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  14 in total

1.  Early distal axonopathy of the visual pathway in experimental diabetes.

Authors:  Diego C Fernandez; Laura A Pasquini; Damián Dorfman; Hernán J Aldana Marcos; Ruth E Rosenstein
Journal:  Am J Pathol       Date:  2011-11-10       Impact factor: 4.307

2.  Evaluation of optic disc, retinal nerve fiber and macular ganglion cell layers in pediatric diabetes.

Authors:  Evre Pekel; Selda Ayça Altıncık; Gökhan Pekel
Journal:  Int Ophthalmol       Date:  2017-08-05       Impact factor: 2.031

Review 3.  Current approaches to the management of diabetic retinopathy and diabetic macular oedema.

Authors:  Francesco Boscia
Journal:  Drugs       Date:  2010-11-12       Impact factor: 9.546

Review 4.  Psychophysical Exams as Early Indicators of Diabetic Retinopathy.

Authors:  Nicola Pescosolido; Giuseppe Buomprisco
Journal:  Eur Endocrinol       Date:  2014-02-28

5.  Intraocular pressure fluctuation and neurodegeneration in the diabetic rat retina.

Authors:  Kyoung In Jung; Jung Eun Woo; Chan Kee Park
Journal:  Br J Pharmacol       Date:  2020-04-15       Impact factor: 8.739

Review 6.  A critical review: Psychophysical assessments of diabetic retinopathy.

Authors:  Xing D Chen; Thomas W Gardner
Journal:  Surv Ophthalmol       Date:  2020-08-29       Impact factor: 6.048

7.  Ischemic conditioning protects from axoglial alterations of the optic pathway induced by experimental diabetes in rats.

Authors:  Diego C Fernandez; Laura A Pasquini; Damián Dorfman; Hernán J Aldana Marcos; Ruth E Rosenstein
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

8.  Effect of the administration of alpha-lipoic acid on contrast sensitivity in patients with type 1 and type 2 diabetes.

Authors:  Anna Gębka; Ewelina Serkies-Minuth; Dorota Raczyńska
Journal:  Mediators Inflamm       Date:  2014-02-10       Impact factor: 4.711

9.  Pilot Study on Visual Function and Fundus Autofluorescence Assessment in Diabetic Patients.

Authors:  Ana M Calvo-Maroto; José J Esteve-Taboada; Rafael J Pérez-Cambrodí; David Madrid-Costa; Alejandro Cerviño
Journal:  J Ophthalmol       Date:  2016-02-10       Impact factor: 1.909

Review 10.  Diabetic photoreceptors: Mechanisms underlying changes in structure and function.

Authors:  Silke Becker; Lara S Carroll; Frans Vinberg
Journal:  Vis Neurosci       Date:  2020-10-06       Impact factor: 3.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.